Hemaguno, 60 Caps (SFR)
Product Info ► Label Info ► Articles
Hemaguno [Product Information]: |
Introducing...Hemaguno!
Maximal Myogenic Enhancement Compound!
Hemaguno™ is an amazing addition to the nutritional prosteroidal market. Its active ingredient, 2a,3a-epithio-17a- methyletioallocholanol 0.0125g (12.5mg per tablet) is a chemical analog of a steroidal aromatase inhibitor used safely in Japan for decades. But this is not the only thing that makes Hemoguno™ special: The ingredient in Hemaguno™ has an amazing "myotrophic-inducing profile" and when compared to similar products currently on the market, it is immediately clear that Hemaguno™ is vastly superior on a milligram-per-milligram basis (see Table).
| PRODUCT |
ACTIVE INGREDIENT |
RELATIVE ANDROGENIC SIDE EFFECT |
RELATIVE MYOTROPHIC INDUCEMENT |
| Hemaguno™ |
2,3- epithio-17- methyletioallocholanol |
91 |
1100 |
| Halodrol-50™ |
4-chloro-17- methyletioallochol-1, 4-diene-3,17-ol |
36 |
73 |
| Promagnon™ |
4-chloro-17- methyletioallochol-1, 4-diene-3,17-ol |
50 |
56 |
The independent information found in Table A clearly shows that Hemaguno™ is not only 15x more myotrophic than Halodrol-50™ and 20x more myotrophic than ProMagnon, but that Hemaguno™ has a phenomenal “myotrophic ratio” of 12, whereby Halodrol-50™ has a myotrophic ratio of only 2.6 and Pro-Magnon™ a ratio of only 1.1. This means that on a milligram-per-milligram basis Hemaguno™ is far less likely (4.62x less likely than Halodrol-50™ and 10.91x less likely than ProMagnon™) to induce undesirable, androgenic mediated-type side effects such as acne, hair loss, etc.
With Hemaguno™ less is really more. A daily dose of 25mg is the maximum amount needed and many people are able to successfully use less than this amount to see exceptional results. As with all products - especially those in this category, it is very important and absolutely necessary to fully read the instructions and follow them completely.
References:
- Androgens and Anabolic Agents: Chemistry and Pharmacology - by Julius Vida
- Internal Endocrine Therapy - Gan To Kagaku Ryoho. 1984 May;11(5):989-98
|
| Hemaguno [Supplement Facts]: |
| 60 Tablets |
|
| Supplement Facts |
| Serving Size 1 Tablet |
| Servings Per Container 60 |
|
| Amount Per Serving |
% Daily Value |
|
| 2a, 3a-Epithio-17a-Methyletioallocholanol |
12.5 mg |
* |
|
| * Daily Value not established |
|
| Other Ingredients |
| Di-Calcium Phosphate , Stearic Acid , Magnesium Stearate , Natural Peppermint Flavor , Riboflavin , Hydroxypropyl Methylcellulose |
|
Directions: Take 1 tablet 1-2 times per day. Do not exceed more than two (2) tablets in a 24 hour period under any circumstances.
Warnings: In purchasing this product you agree to abide by all of the following warnings for use and contraindications. Please do not use this product prior to consulting with your licensed health care provider (a physician typically). Do not use this product if you are at risk for or are being treated fro high blood pressure, heart, kidney, liver, thyroid or psyciatric disease, anxiety, depression, seizure disorders or stroke. Do not use this product if you are taking antidepressants, MAO/MAOi inhibitors or any other prescription drugs under any circumstances. Not for use in persons under the age of twenty-one (21) or in women under any circumstances. Keep away from children. Discontinue use and consult your health care professional if dizziness, nausea, tremors, nervousness, headache, or heart palpitations occur. Do not exceed recommended dose under any circumstances. Do not use this product if you are trying to conceive a child. Do not use this product for more than 30 days without a 45 day break. If you are subject to performance enhancing drug testing, do not use this product unless cleared by your sanctioning body.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
|
Buy Hemaguno today!
Save more on Hemaguno with our instant coupons and quantity discounts! |
|  | ► Related / You May Also Like: | | | | | | | |
|
|
